Innorna Co., a Chinese developer of messenger RNA drugs backed by buyout firm CDH Investments, is planning an initial public offering in Hong Kong, according to people familiar with the matter. Source: Original Навигация по записям Samsung’s Galaxy XR Headset Debuts at Half the Price of Apple’s Vision Pro SoftBank Seeks to Sell About $2 Billion of Bonds Amid AI Push
